Former Safeway CEO points to red flags in Theranos partnership

Former Theranos CEO Elizabeth Holmes leaves after a hearing at a federal court in San Jose, Calif., on July 17, 2019. [Image courtesy of Reuters/Stephen Lam]

Former Safeway CEO Steve Burd testified at the Elizabeth Holmes trial last week, saying the company’s partnership with Theranos failed due to multiple delays of the blood-testing devices.

Burd thought a partnership with Theranos would be an opportunity for the grocery chain to expand into healthcare, he testified. He said he was drawn to Theranos and its technology because of the claims that the tests could perform blood tests faster, cheaper and without a full laboratory. The former CEO of two decades said he imagined that people could get their blood tested and shop while they wait for results.

Safeway spent hundreds of millions of dollars to build clinics in many of its grocery stores in preparation for the Theranos machines.

Read more

  • 0

Former Safeway CEO points to red flags in Theranos partnership

Former Theranos CEO Elizabeth Holmes leaves after a hearing at a federal court in San Jose, California, on July 17, 2019. [Photo by Stephen Lam/Reuters]Former Safeway CEO Steve Burd testified at the Elizabeth Holmes trial last week, saying the company’s partnership with Theranos failed due to multiple delays of the blood-testing devices.

Burd thought a partnership with Theranos would be an opportunity for the grocery chain to expand into healthcare, he testified. He said he was drawn to Theranos and its technology because of the claims that the tests could perform blood tests faster, cheaper and without a full laboratory. The former CEO of two decades said he imagined that people could get their blood tested and shop while they wait for results.

Safeway spent hundreds of millions of dollars to build clinics in many of its grocery stores in preparation for the Theranos machines.

But repeated delays from the Silicon Valley startup began to raise red fla…

Read more
  • 0

Elizabeth Holmes defense attorneys shift some blame of lab problems onto former lab director

Theranos founder Elizabeth Holmes (center) arrives at federal court in San Jose, California on Aug. 31, 2021. [Photo by David Paul Morris/Bloomberg via Getty Images]Former Theranos lab director Adam Rosendorff took the stand again in the Elizabeth Holmes federal fraud trial to face cross-examination from the defense.

Holmes’ defense attorney Lance Wade alleged that the issues in the lab were a result of Rosendorff’s “incompetence,” Mercury News reports.

“To the extent that failures in the lab are the result of incompetence of someone other than my client, it’s exculpatory for my client,” Holmes’ defense attorney Lance Wade said, Mercury News reports.

Rosendorff testified that he was under “tremendous pressure” to show that the Theranos blood-testing technology worked and was successful, CNBC reports. He said the pressure came from the top and went all the way through research and development.

Rosendorff reite…

Read more
  • 0

Celgene scientist testifies to dismantled partnerships with Theranos due to poor test quality

Former Theranos CEO Elizabeth Holmes leaves after a hearing at a federal court in San Jose, Calif., on July 17, 2019. [Image courtesy of Reuters/Stephen Lam]

A former Celgene scientist took the stand on Wednesday in the Elizabeth Holmes federal fraud trial to testify to a partnership the company had with Theranos on certain projects.

Victoria Sung testified about speaking to Theranos in 2009 about helping the biopharmaceutical company in a drug trial for a medication that was in development to treat anemia. She said that the small, compact size of the Theranos devices were appealing to her, the Wall Street Journal reports.

Sung alleged that Celgene vetted the Theranos technology against “gold-standard” blood testing partners and did not have confidence in the results. She testified that the results provided by Theranos didn’t match to a degree that Celgene would have preferred and were “out of range,” Th…

Read more
  • 0

Celgene scientist testifies to failed partnerships with Theranos due to poor test quality

Former Theranos CEO Elizabeth Holmes leaves after a hearing at a federal court in San Jose, Calif., on July 17, 2019. [Image courtesy of Reuters/Stephen Lam]A former Celgene scientist took the stand on Wednesday in the Elizabeth Holmes federal fraud trial to testify to a partnership the company had with Theranos on certain projects.

Victoria Sung testified about speaking to Theranos in 2009 about helping the biopharmaceutical company in a drug trial for a medication that was in development to treat anemia. She said that the small, compact size of the Theranos devices were appealing to her, the Wall Street Journal reports.

Sung alleged that Celgene vetted the Theranos technology against “gold-standard” blood testing partners and did not have confidence in the results. She testified that the results provided by Theranos didn’t match to a degree that Celgene would have preferred and were “out of range,” The Verge reports. Sung told assis…

Read more
  • 0

Former Theranos lab director faces cross-examination, says he was source for Wall Street Journal uncoverings

Theranos founder Elizabeth Holmes (center) arrives at federal court in San Jose, California on Aug. 31, 2021.[Photo by David Paul Morris/Bloomberg via Getty Images]

Former Theranos lab director Adam Rosendorff took the stand for a second day at the Elizabeth Holmes federal fraud trial to face cross-examination from the defense.

The lab director testified that he felt pressured by management to defend lab tests despite the inaccuracies, multiple media sources report. For example, in several email exchanges with Holmes’ brother Christian Holmes, Rosendorff was asked to come up with “constructive” ways of dealing with a doctor who was questioning the results of a cholesterol test performed by one of Theranos’ machines.

Rosendorff said that he told Christian Holmes that, “if you are asking me to defend these values, then the answer is no,” NBC Bay Area reports. Rosendorff also said in the email exchange that…

Read more
  • 0

Former Theranos lab director faces cross-examination, says he was source for Wall Street Journal uncoverings

Theranos founder Elizabeth Holmes (center) arrives at federal court in San Jose, California on Aug. 31, 2021. [Photo by David Paul Morris/Bloomberg via Getty Images]Former Theranos lab director Adam Rosendorff took the stand for a second day at the Elizabeth Holmes federal fraud trial to face cross-examination from the defense.

The lab director testified that he felt pressured by management to defend lab tests despite the inaccuracies, multiple media sources report. In several email exchanges with Holmes’ brother Christian Holmes, Rosendorff was asked to come up with “constructive” ways of dealing with a doctor who was questioning the results of a cholesterol test performed by one of Theranos’ machines.

Rosendorff said that he told Christian Holmes that, “if you are asking me to defend these values then the answer is no,” NBC Bay Area reports. Rosendorff also said in the email exchange that he thought the most “constructiv…

Read more
  • 0

Former Theranos lab director takes the stand, says Elizabeth Holmes was ‘nervous’ amid blood test inaccuracy concerns

Former Theranos CEO Elizabeth Holmes leaves after a hearing at a federal court in San Jose, Calif., on July 17, 2019. [Image courtesy of Reuters/Stephen Lam]A former Theranos lab director testified on Friday in the Elizabeth Holmes federal fraud trial that the company was aware of the multiple concerns raised by physicians and Theranos employees prior to the Walgreens launch.

Adam Rosendorff, a Theranos lab director from 2013 until late 2014, testified that Holmes and other top executives were pushing him to validate tests that he was not confident in, CNBC reports. The former lab director testified that he sent an email to Holmes in August 2013 that said that the blood-testing device was not ready for a launch in Walgreens stores. He also raised issues related to the training and staffing in the laboratory.

Rosendorff also spoke directly with Holmes, who had a countdown of the days until the Walgreens launch posted on her office window, regarding the concerns spe…

Read more
  • 0

Former defense chief James Mattis testifies in Elizabeth Holmes federal fraud trial

Former Theranos CEO Elizabeth Holmes leaves after a hearing at a federal court in San Jose, Calif., on July 17, 2019. [Image courtesy of Reuters/Stephen Lam]Former U.S. Secretary of Defense James Mattis testified on Wednesday in Elizabeth Holmes’ federal fraud trial that she misled him into believing the Theranos technology could save the lives of troops in battle.

Four-star Gen. Mattis testified that he first met Holmes in 2011 while still serving in the Marine Corps. where he oversaw troops and the wars in Iraq and Afghanistan. After his retirement from the U.S. in 2013, Mattis joined Theranos’ board of directors and invested $85,000 of his own money into the Silicon Valley startup, according to multiple media reports. He later became the secretary of defense under former President Donald Trump in 2017.

Mattis said that Holmes appeared to be in control of the company and allegedly told board members what to discuss with the press during her time at t…

Read more
  • 0

First Theranos patient takes the stand, defense begins to shift blame on Sunny Balwani

Theranos founder Elizabeth Holmes (center) arrives at federal court in San Jose, California on Aug. 31, 2021. [Photo by David Paul Morris/Bloomberg via Getty Images]A former Theranos patient took the stand at Elizabeth Holmes’ federal fraud trial to testify that the blood testing technology inaccurately showed she was having a miscarriage.

Brittany Gould testified on Tuesday that she had taken two Theranos blood tests at a Walgreens location in Arizona that both indicated her hCG levels were dropping, according to multiple media reports.

Gould’s nurse practitioner Audra Zachman received the Theranos test results and told her that the results indicated that she was miscarrying and the pair allegedly discussed terminating the pregnancy due to the test results, Silicon Valley News reports.

However, Gould testified that she took three other tests during her early pregnancy through Quest Diagnostics – one prior to the Theranos test and two after – th…

Read more
  • 0

Former Theranos scientist testifies to blood test inaccuracies prior to Walgreens deal in Elizabeth Holmes trial

Former Theranos CEO Elizabeth Holmes leaves after a hearing at a federal court in San Jose, Calif., on July 17, 2019. [Image courtesy of Reuters/Stephen Lam]

A former Theranos scientist testified on the inaccuracies of the company’s device during Elizabeth Holmes’ federal fraud trial.

Surekha Gangakhedhar worked at Theranos from 2005 to 2013 and reported directly to Holmes at one point. She testified on Friday that Holmes allegedly pressured her to validate blood test results to speed up a rollout of the Edison device to several Walgreens locations despite its inaccuracies, CNBC reports.

Gangakhedkar said that she returned from a vacation in August 2013 to discover that the company was on track to launch the Edison 3.0 and 3.5 in Walgreens stores. She resigned from the company the following month because she was uncomfortable with the pending launch and plans to test patient blood samples. Gangakhedkar m…

Read more
  • 0

Former Theranos scientist testifies to blood test inaccuracies prior to Walgreens deal in Elizabeth Holmes trial

Former Theranos CEO Elizabeth Holmes leaves after a hearing at a federal court in San Jose, Calif., on July 17, 2019. [Image courtesy of Reuters/Stephen Lam]A former Theranos scientist testified on Friday on the inaccuracies of the company’s device during Elizabeth Holmes’ federal fraud trial.

Surekha Gangakhedhar, who worked at Theranos from 2005 to 2013 and reported directly to Holmes at one point, testified that Holmes allegedly pressured her to validate blood test results to speed up a rollout of the Edison device to a number of Walgreens locations despite its inaccuracies, CNBC reports.

Gangakhedkar said that she returned from vacation in August 2013 to discover that the company was on track to launch the Edison 3.0 and 3.5 in Walgreens stores. She resigned from the company the following month because she was uncomfortable with the pending launch and plans to test patient blood samples. Gangakhedkar met with Holmes prior to her resignation to disc…

Read more
  • 0